ArticleACS nano2026
Quad-Channel In Vivo Photoacoustic Multiplexing Using Tunable Gold Nanorods.
Article in ACS nano, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Photoacoustic (PA) imaging combines the molecular specificity of optical absorption with the resolution and depth of ultrasound, enabling noninvasive molecular imaging in vivo. However, robust and accurate PA multiplexing is hindered by the broad spectra and poor photostability of existing contrast agents, and interference from endogenous absorbers. Here, we demonstrate four-channel PA multiplexing using PEGylated silica-coated gold nanorods with narrow, spectrally distinct plasmon resonances spanning the near-infrared window. A reproducible three-step seed-mediated synthesis yields monodisperse, spectrally tunable gold nanorods. Co-hybrid silica encapsulation with PEGylation enhances photostability and standardizes both particle dimensions and surface chemistries across the panel. With only a commercial OPO laser and a straightforward non-negative least-squares algorithm, we achieve accurate signal separation across a full-factorial set of in vitro and in vivo models, maintaining mean absolute errors below 4.3%. We further show that the nanorod library remains clearly distinguishable in the presence of endogenous oxyhemoglobin and deoxyhemoglobin and can be unmixed using VisualSonics native spectral deconvolution. This platform doubles existing PA multiplexing capabilities to four exogenous channels without requiring multimodal imaging, complex laser setups, or complicated computational pipelines. This work establishes a framework for future applications in noninvasive biomarker mapping, multicellular therapies, and spatially resolved diagnostics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.